bpc 157 peter attia 387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field - The Drive - Private Subscriber Feed (🔓) peter attia bpc 157 Austin
Description
Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase
Beyond Ozempic , emerging therapies like AOD-9604 , 5-Amino-1MQ, CJC-1295, Ipamorelin, and MOTS-c are expanding our arsenal and giving patients options
View our lab testing program Does formulation format alter the underlying pharmacological properties of BPC-157
doi: 10.1080/01443615.2020.1732891
Anywhere else you want us to point them to make sure they can connect with you
